|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash flows from operating activities: | |
| Net Income Loss | |
| Adjustments to reconcile net loss to net cash used in operating activities | |
| Depreciation and amortization | |
| Stock-based compensation expense | |
| Non-cash operating lease expense | |
| Common stock issued in exchange for services | |
| Net gain from change in fair value of derivative liability instrument | |
| Gain from change in fair value of forward contract liability | |
| Amortization of deferred offering cost | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses and other current assets | |
| Accounts payable and accrued expenses | |
| Net cash used in operating activities | |
| Cash flows from investing activities: | |
| Purchases of intangible assets | |
| Net cash used in investing activities | |
| Cash flows from financing activities: | |
| Net cash provided by financing activities | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of year | |
| Cash and cash equivalents at end of year | |
| Supplemental disclosure of non-cash activities | |
| Common stock issued for deferred offering cost | |
| Settlement of forward contract liability for sale of shares to GEM pursuant to Initial Draw Down Notice | |
| Issuance of warrant under Share Purchase Agreement for deferred offering costs |
Loading...
